Erin M. Taylor

OverviewAI-generated summary

Erin M. Taylor's research focuses on several areas within health and medical sciences, including cancer-related molecular mechanisms and immune response and inflammation. Taylor has investigated the use of CRISPR/dCas9-KRAB to suppress S100b and restore p53-mediated apoptosis in melanoma cells. Additionally, Taylor's work includes studies on TCF1–LEF1 co-expression to identify multipotent progenitor cells involved in human allergic diseases. Other research interests encompass surgical management of conditions such as hidradenitis suppurativa and breast cancer-associated lymphedema, with publications detailing trial protocols for comparing microsurgical and conservative treatments for chronic breast cancer-related lymphedema. Taylor's scholarly contributions are reflected in an h-index of 14 and over 700 citations across 57 publications. Key collaborators include Brian Koss, Aaron J. Storey, Samrat Roy Choudhury, and Sara Shalin, all from the University of Arkansas for Medical Sciences, with whom Taylor has co-authored multiple publications.

Metrics

• h-index: 14
• Publications: 57
• Citations: 734